NovoCure
$13.02
142
+$0.79+6.46% Wednesday 20:00
Statistics
Day High
13.16
Day Low
12.43
52W High
19.4
52W Low
10.03
Volume
1,216,551
Avg. Volume
-
Mkt Cap
1.46B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
30AprExpected
Expected EPS
-0.512186
Actual EPS
N/A
Financials
-20.79%Profit Margin
Unprofitable1.31BRevenue
-272.45MNet Income
Analyst Ratings
33.5Average Price Target
The highest estimate is 49.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 50%
Hold 50%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NVCR. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Zimmer Biomet
ZBH
Mkt Cap18.54B
Intuitive Surgical
ISRG
Mkt Cap166.65B
Medtronic
MDT
Mkt Cap110.66B
Boston Scientific
BSX
Mkt Cap95.46B
Stryker
SYK
Mkt Cap131.49B
Abbvie
ABBV
Mkt Cap368.57B
Merck
MRK
Mkt Cap294.39B
Pfizer
PFE
Mkt Cap156.77B
Johnson & Johnson
JNJ
Mkt Cap564.35B
About
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
Show more...
CEO
Mr. William F. Doyle
Employees
1488
Country
United Kingdom
ISIN
JE00BYSS4X48
Listings
0 Comments
Share your thoughts
FAQ
What is NovoCure stock price today?▼
The current price of NVCR is $13.02 USD — it has increased by +6.46% in the past 24 hours. Watch NovoCure stock price performance more closely on the chart.
What is NovoCure stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange NovoCure stocks are traded under the ticker NVCR.
Is NovoCure stock price growing?▼
NVCR stock has risen by +3.17% compared to the previous week, the month change is a +10.15% rise, over the last year NovoCure has showed a -26.73% decrease.
What is NovoCure market cap?▼
Today NovoCure has the market capitalization of 1.46B
When is the next NovoCure earnings date?▼
NovoCure is going to release the next earnings report on April 30, 2026.
What were NovoCure earnings last quarter?▼
NVCR earnings for the last quarter are -0.22 USD per share, whereas the estimation was -0.41 USD resulting in a +46.53% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is NovoCure revenue for the last year?▼
NovoCure revenue for the last year amounts to 1.31B USD.
What is NovoCure net income for the last year?▼
NVCR net income for the last year is -272.45M USD.
How many employees does NovoCure have?▼
As of April 23, 2026, the company has 1,488 employees.
In which sector is NovoCure located?▼
NovoCure operates in the Health & Wellness sector.
When did NovoCure complete a stock split?▼
NovoCure has not had any recent stock splits.
Where is NovoCure headquartered?▼
NovoCure is headquartered in Baar, United Kingdom.